Reprise Biomedical, Inc. — Form D

Reprise Biomedical, Inc. of Plymouth, MN, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-11. The offering totals $7.0M, of which $6.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Ronald EibensteinerDirectorPlymouth, MN
Erwin KelenDirectorPlymouth, MN
Phil NalboneDirectorPlymouth, MN
Carrie PowersDirectorPlymouth, MN
Howard RootDirectorPlymouth, MN
Alan WoldtDirectorPlymouth, MN
Jeff DuncanExecutive OfficerPlymouth, MN
Jake IsenburgExecutive OfficerPlymouth, MN
Steve JagodzinskiExecutive OfficerPlymouth, MN
Heather KotilaExecutive OfficerPlymouth, MN
Tom KouchoukosExecutive OfficerPlymouth, MN
Jerrod KruegerExecutive OfficerPlymouth, MN
Carrie PowersExecutive OfficerPlymouth, MN
Greg SmockExecutive OfficerPlymouth, MN
Jeff RossDirectorEden Prairie, MN
Jake IsenburgRelated PersonPlymouth, MN
Carrie PowersRelated PersonPlymouth, MN
Ronald EibensteinerRelated PersonPlymouth, MN
Phil NalboneRelated PersonPlymouth, MN
Howard RootExecutive OfficerPlymouth, MN
Howard RootRelated PersonPlymouth, MN
Tom KouchoukosRelated PersonPlymouth, MN
Erwin KelenRelated PersonPlymouth, MN
Alan WoldtRelated PersonPlymouth, MN
Jerrod KruegerRelated PersonPlymouth, MN

Other filings by this issuer (9)

FiledFormOfferingSold
2026-07-01D/A$10.0M$9.2M
2026-05-21D$8.0M$1.4M
2023-12-13D/A$12.5M$8.0M
2023-11-02D$10.0M$4.5M
2023-01-25D/A$15.3M$15.3M
2023-01-03D$14.8M$13.0M
2021-03-31D/A$5.0M$5.0M
2020-11-25D$5.0M$2.8M
2019-07-12D$12.5M$12.5M

More